Lamotrigine Tablet
Product Images NDC 65841-687

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 65841-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 06

Lamotrigine Tablets for Oral Suspension USP, 5 mg chewable, dispersible tablets by Zydus Lifesciences Limited. The label shows the NDC 65841-689-01 and indicates a package of 100 tablets, Rx only. The tablet is round, imprinted with 'Z 13'. The label includes usage cautions, storage instructions, and manufacturer details from Cadila Healthcare Ltd, Ahmedabad, India.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 07

Lamotrigine 25 mg chewable, dispersible tablets for oral suspension in a bottle containing 100 tablets. The label shows the Zydus Pharmaceuticals logo and indicates the tablets are prescription-only. It includes cautions to verify the product dispensed and to dispense the accompanying medication guide. The label also displays a sample tablet imprint 'Z 12' and storage instructions.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 08

Lamotrigine Tablets, USP 25 mg oral tablets label from Zydus Lifesciences Limited indicating a package of 100 tablets. The label includes a caution to verify the product dispensed, pharmacist instructions to dispense the medication guide, storage instructions, and warnings about the printed seal and keeping the drug out of reach of children. The tablet is depicted as round and white with markings.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 09

Lamotrigine Tablets, USP 50 mg oral tablets packaging label. The label includes NDC 65841-683-01 and indicates a bottle count of 100 tablets. Manufacturer is Zydus Lifesciences Limited. Directions note to verify product dispensing and keep out of reach of children.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 10

Packaging label for Lamotrigine Tablets USP 100 mg, an oral tablet prescription drug. The label shows the NDC number 65841-684-01 and features a white and pink design with the Zydus Pharmaceuticals logo. It includes a tablet image embossed with 'ZG 30', caution statements for pharmacists, storage instructions, and manufacturer information for Cadila Healthcare Ltd., India. The package contains 100 tablets.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 11

Lamotrigine Tablets USP 150 mg oral tablets label showing a bottle cap imprint ZC 81, 60 tablets per bottle. The label includes the NDC 65841-685-14, manufacturer Zydus Pharmaceuticals, and storage instructions. It cautions pharmacists to verify the product and includes warnings for secure dispensing and storage out of children's reach.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 12

Lamotrigine Tablets, USP 200 mg oral tablets are shown on a rectangular white and purple label. The label includes the NDC 65841-686-14 and states the package contains 60 tablets for prescription use only. The label displays a round, scored tablet imprinted with 'ZC 82'. It carries warnings and storage instructions, and identifies Zydus Pharmaceuticals and Cadila Healthcare Ltd, India, as the labeler and manufacturer respectively.*

FDA Label Image

3c16aa5d Dae5 42ac 9af9 Eb55052968c6 13

The packaging label for Lamotrigine Tablets, USP, 250 mg oral tablets, supplied by Zydus Lifesciences Limited. The label indicates a package quantity of 500 tablets, includes dispensing cautions for pharmacists, and contains storage instructions and warnings typical for prescription medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.